Related Experiment Video
Updated: Jul 11, 2026
11:28
Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Injection drug use, multiple hepatitis virus infections, and migration: a German study
Jens Reimer1, Juergen Lorenzen, Bernhard Baetz
1Centre for Interdisciplinary Addiction Research, University of Hamburg, Hamburg, Germany. reimer@uke.uni-hamburg.de
Substance Use & Misuse
|September 22, 2007
Summary
Injection drug users from ethnic minorities experienced more severe addiction and higher rates of viral hepatitis A, B, and C infections. Culturally sensitive treatment programs are recommended for this population.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Viral hepatitis A, B, and C are significant health concerns, particularly among vulnerable populations.
- Injection drug use is a major risk factor for hepatitis virus transmission.
- Socioethnic factors may influence addiction severity and infection rates.
Purpose of the Study:
- To investigate the prevalence of viral hepatitis A, B, and C infections.
- To examine the association between socioethnic factors and hepatitis infection and addiction severity in injection drug users.
- To inform the development of targeted public health interventions.
Main Methods:
- Cross-sectional study of 1499 patients at a rural German hospital (2001-2003).
- Data collection included sociodemographic, drug-related information, and serology for hepatitis A, B, and C.
- Statistical analysis using univariate ANOVA, Scheffé tests, chi(2) test, and Bonferroni adjustment.
Main Results:
- Ethnic minority patients reported a more severe addiction course.
- Higher frequencies of hepatitis A, B, and C infections were observed in ethnic minority patients.
- Significant associations were found between socioethnic factors and hepatitis infection and addiction severity.
Conclusions:
- Socioethnic factors play a role in the severity of addiction and hepatitis virus infection among injection drug users.
- There is a need for low-threshold, culture-sensitive drug user treatment programs.
- Further evaluation of such programs is recommended to improve health outcomes.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:16Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...